Abstract:R eperfusion therapy is beneficial to prevent cardiomyocyte death and contractile dysfunction after myocardial infarction. However, numerous studies have shown that reperfusion itself may enhance the injury, resulting in the increase of infarct size after ischemia [ie, ischemiareperfusion (I/R) injury]. Although both ischemic preconditioning and pharmacological preconditioning mimetics strongly protect the heart against I/R injury, the requirement for pretreatment has greatly limited their clinical relevance. Meanwhile, it has been recently reported that brief intermittent ischemia applied after the onset of reperfusion, termed “postconditioning,” reduces myocardial injury to an extent comparable to the reduction by preconditioning. Various cardioprotective mechanisms of postconditioning have been proposed, and pharmacological postconditioning by the administration of agents that modulate these mechanisms seems to be beneficial in I/R injury. Hydrogen sulfide (H2S) is a colorless, flammable gas with a characteristic odor, which, until recently, had been known for its toxicity alone. However, H2S is now known to be a novel gaseous signaling molecule, similar to nitric oxide (NO) and carbon monoxide, and is endogenously produced in mammalian tissues. Notably, a growing body of evidence has shown that H2S is a critical regulator of cardiac functions and plays a protective role in the pathogenesis and development of heart diseases such as myocardial infarction, arrhythmia, hypertrophy, fibrosis, and I/R injury. Some mechanisms have been proposed by which H2S exerts cardioprotective effects, including reduction of apoptosis, preservation of mitochondrial function, anti-inflammatory responses, and angiogenic actions. However, the specific mechanism of cardioprotection mediated by H2S in I/R injury is still largely unknown.

The emerging role and therapeutic implications of bacterial and parasitic deubiquitinating enzymes

Recent Progress of Deubiquitinating Enzymes in Human and Plant Pathogenic Fungi

Role of Virally-Encoded Deubiquitinating Enzymes in Regulation of the Virus Life Cycle

The Functional Deubiquitinating Enzymes in Control of Innate Antiviral Immunity

Hydrogen Sulfide, a Potential Cardioprotective Gas Activating a Life Span Regulator.

The Emerging Role of Deubiquitinating Enzymes in Genomic Integrity, Diseases, and Therapeutics.

Deubiquitylating Enzymes in Cancer and Immunity

An Integrated View of Deubiquitinating Enzymes Involved in Type I Interferon Signaling, Host Defense and Antiviral Activities

Emerging Role of DUBs in Tumor Metastasis and Apoptosis: Therapeutic Implication

Deubiquitinating Enzymes Related to Autophagy: New Therapeutic Opportunities?

Deubiquitinating enzymes: potential regulators of the tumor microenvironment and implications for immune evasion

A review of deubiquitinases and thier roles in tumorigenesis and development

Exploitation of the host cell ubiquitin machinery by microbial effector proteins

On the Study of Deubiquitinases: Using the Right Tools for the Job

Recent advances in the development of deubiquitinases inhibitors as antitumor agents

Post-Translational Modifications of Deubiquitinating Enzymes: Expanding the Ubiquitin Code

Advance in Research on the Regulation of Innate Immune Response by Ubiquitination

Cellular Deubiquitylating Enzyme: A Regulatory Factor of Antiviral Innate Immunity

Ubiquitin-Dependent and Independent Proteasomal Degradation in Host-Pathogen Interactions

Deubiquitylating enzymes in neuronal health and disease

Viral deubiquitinating proteases and the promising strategies of their inhibition